O ukexilu ua kusaka o uhaxi ua izavu, u bhinga kuijiia se o uhaxi ua bhonzo mba kana, o haxi ué uejiia o ukexilu ua kusaka.
O ukexilu ua kusaka u tena ku kuatekesa:
1. Ku bhanga pelasá: O pelasá íii, phala ku katula o kijimbu ni ima ia mukuá iala moxi dia kimbi.
Kuene maukexilu avulu a ku bhanga pelasá, kála o ku katula o kijimbu, o mama u katula o mona, ni idiandu ia mukuá ku mukutu.
2. Milongo phala ku saka o uhaxi ua izavu: O milongo íii, i jibha o ji célula ja uhaxi ua izavu, ni ku sosolola o uhaxi.
O ji dotolo a bhanga kiki phala ku jibha o ji célula ja iibha.
3. Milongo phala ku sosolola o uhaxi: O milongo íii, i kuatekesa ku jibha o ji célula ja uhaxi.
O milongo íii a tena ku i bhana mu phutu, mba ku i tambula mu kanu, phala ku sosolola o uhaxi ande dia ku bhanga pelasá, mba phala ku jibha o ji célula ja uhaxi.
4. Milongo phala ku sosolola o ji célula ja uongo: O milongo íii phala ku sosolola o ji célula ja uongo, phala ki ji sabhuke dingi.
5. Milongo phala ku sosolola o uhaxi: O milongo íii, i kuatekesa o ji célula ja câncer ku kula ni ku di muanga.
6. Milongo phala ku fidisa o uhaxi: O milongo íii, i kuatekesa o mukutu uetu ku bhânga ni ji célula ja câncer.
7. Milongi phala ku mona se o milongo iambote: O jihaxi a tena ku xikina ku di longa o milongo phala ku mona se a-nda tena ku saka o uhaxi uâ.
Kima kiambote kuzuela ni dotolo ia lungu ni ukexilu uambote ua ku saka o uhaxi iú, mukonda o dotolo ua-nda sola o ukexilu ua tokala phala o muthu.
O milongo íii i tena ku kuatekesa ué o muthu ua kate, ni ku mu kuatekesa mu ukexilu ua nzumbi.
Kumar L, Baldi A, Verma S, Utreja P: Exploring Therapeutic Potential of Nanocarrier Systems Against Breast Cancer. Pharm Nanotechnol. 2018, 6 (2): 94-110.
Mehrgou A, Akouchekian M: Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease. J Res Med Sci. 2017, 22 (): 130.
Ng AK, Travis LB: Radiation therapy and breast cancer risk. J Natl Compr Canc Netw. 2009, 7 (10): 1121-8.
Ligresti G, Libra M, Militello L, Clementi S, Donia M, Imbesi R, Malaponte G, Cappellani A, McCubrey JA, Stivala F: Breast cancer: Molecular basis and therapeutic strategies (Review). Mol Med Rep. , 1 (4): 451-8.
Bricou A, Barranger E: Response to the article by Evangelista et al.: Use of a portable gamma camera for guiding surgical treatment in locally advanced breast cancer in a post-neoadjuvant therapy setting. Breast Cancer Res Treat 2014. Breast Cancer Res Treat. 2014, 148 (1): 231-2.
Daniyal A, Santoso I, Gunawan NHP, Barliana MI, Abdulah R: Genetic Influences in Breast Cancer Drug Resistance. Breast Cancer (Dove Med Press). 2021, 13 (): 59-85.
Li X, Bu X: Progress in Vaccine Therapies for Breast Cancer. Adv Exp Med Biol. 2017, 1026 (): 315-330.
['Kitendelesu:']
['O kijimbuete kiki, phala ku longa ngó, ki kiene mu bhana milongi ia lungu ni sauidi.']
['O milongi íii, ka tokala ku i tumbula phala ku saka uhaxi, mba ku saka mauhaxi a mukuá.']
['Mu kifika, o ji komputadolo jene mu kuatekesa o athu kuijiia o ima ia lungu ni uhaxi, ki ji tena ku jimbulula kiambote o maka.']
['Sota kikuatekesu kia dotolo iê mba muthu ua mukuá uala ni uhete ua ku saka mauhaxi. Kana ku jimba o itendelesu ia dotolo mukonda dia milongi i ua tange mu kijimbuete kiki. Se ua mesena kikuatekesu, xinda ku muxinda ua 112, mba ndé mu inzo ia ku saka ia zukama.']
['Iala ni Kikutu ni Jinguvulu ja Jixi Jengi']
['O Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (o DMCA) i bhana ku athu ala ni ufolo ua ku soneka, o ima ia mona mu Internete, i bhukumukina o ufolo uâ ua ku soneka. ']
['Se eie u xikina ni kidi kioso kuila o milongi mba milongi i ua mu tanga mu kijimbuete kietu kia internete, mba mu ima ia mukuá, ia mu bhukumukina o itumu iê, eie (mba o muthu u ua mu tumina) u tena ku tu tumikisa mukanda ni ku tu bhinga phala ku katula o milongi mba milongi i ua mu tanga mba ku fidisa o muthu ku i tanga.']
['O ngolokela a tokala ku i tumikisa mu mukanda ni mu kijimbuete kia i-me-le (Tala o mbandu "Utuameni ua Ijimbuete") ].']
['O DMCA i bhinga kuila o njimbu iê ia lungu ni ku bhukumukina o itumu ia ku tokala, i kala ni milongi íii: (1) kijimbuluilu kia kikalakalu kia tokala ku kitumu kia ku tokala; (2) kijimbuluilu kia milongi ia ku tokala ni milongi i tua tokala ku sanga; (3) o ijimbuete iê, ni ijimbuete ia mutelembe uê; (4) ni izuelu i ua zuela kuila eie u xikina ni kidi kioso kuila o milongi ia ku tokala, ki i tokala ku ngana ia tokala, mba ku mukunji uê, mba ku kitumu kioso-kioso; ']
['(5) O kijimbuete kiê, ni kijimbuete kia ku tangela kuila o milongi iala mu kijimbuete kiki ia kidi, ni kuila eie uala ni kutena kua ku langa o ima ia ku tokala;']
['O kijimbuete kiki, ki tena ku kala ni kidimbu kiê, mba kijimbuete kia muthu ua mu tumina o ku ki jikula.']
['Se ku soneka o ima ioso íii, o ku tokuesa o maka mê kua-nda laleka.']
['Kuzuela ni Muthu']
['Tua ku dióndo, tu tumikise njimbu ni ibhuidisu mba jindunge.']
How to treat breast cancer?
The treatment for breast cancer depends on various factors such as the stage of cancer, the type of cancer, the patient's overall health, and personal preferences.
Some common treatment options include:
1. Surgery: This involves removing the tumor and surrounding tissue.
There are different types of surgery, including lumpectomy, mastectomy, and lymph node removal.
2. Radiation therapy: This uses high-energy radiation to kill cancer cells and shrink tumors.
It is often used after surgery to kill any remaining cancer cells.
3. Chemotherapy: This involves using drugs to kill cancer cells.
It can be given intravenously or or orally and is often used to shrink tumors before surgery or to kill any remaining cancer cells after surgery.
4. Hormone therapy: This is used for hormone-receptor-positive breast cancers and works by blocking the hormones that fuel the growth of cancer cells.
5. Targeted therapy: This uses drugs that target specific molecules involved in the growth and spread of cancer cells.
6. Immunotherapy: This helps the immune system recognize and attack cancer cells.
7. Clinical trials: Patients may also consider participating in clinical trials to access new and experimental treatments.
It is important to discuss the best treatment options with a healthcare team, as the treatment plan will be tailored to the individual's specific needs and circumstances.
Additionally, supportive care such as pain management, emotional support, and nutritional guidance may also be part of the treatment plan.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['O ku']
['O BioMedLib i kalakala ni ji komputadolo phala ku bhanga ibhuidisu ni itambuijilu.']
['Tua mateka ni 35 a mazunda a madivulu a lungu ni sauidi mu internete, ni madivulu a mukuá a ubhe.']
['Tanga o mbandu "Referências" ni mbandu "Disclaimer".']
